Dendritic Cell-based Immunotherapy for the Treatment of Hematological Malignancies

Author： Büchler Tomas   Michalek Jaroslav   Kovarova Lucie   Musilova Romana   Hajek Roman  

Publisher： Maney Publishing

ISSN： 1024-5332

Source： Hematology, Vol.8, Iss.2, 2003-01, pp. : 97-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Potential use of Dendritic Cell-based Immunotherapy for Treatment of Pancreatic Cancer

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 9, Iss. 4, 2009-12 ,pp. : 191-202

Bentham Science Publishers

Access to resources Recommend Favorite

Viral vectors for dendritic cell-based immunotherapy

By Jenne L.   Schuler G.   Steinkasserer A.  

Trends in Immunology, Vol. 22, Iss. 2, 2001-02 ,pp. : 102-107

Elsevier

Access to resources Recommend Favorite

Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review

By Baron Frédéric  

Springer Seminars in Immunopathology, Vol. 26, Iss. 1-2, 2004-11 ,pp. : 71-94

Springer Publishing Company

Access to resources Recommend Favorite

Dendritic cell-based cancer immunotherapies

By Fujii Shin-ichiro  

Archivum Immunologiae et Therapiae Experimentalis, Vol. 57, Iss. 3, 2009-06 ,pp. : 189-198

Springer Publishing Company

Access to resources Recommend Favorite

Monitoring of CD4+ and CD8+ T-Cell Responses After Dendritic Cell-Based Immunotherapy Using CFSE Dye Dilution Analysis

By PUTZ THOMAS   RAMONER REINHOLD   GANDER HUBERT   RAHM ANDREA   BARTSCH GEORG   HÖLTL LORENZ   THURNHER MARTIN  

Journal of Clinical Immunology, Vol. 24, Iss. 6, 2004-11 ,pp. : 653-663

Springer Publishing Company

Access to resources Recommend Favorite